News About: Pharm. Industry
Local drugmakers seeking to tackle falling revenue
A plethora of major issues are slated to affect Korean industries this year, including a massive price -cut plan starting April.
The forecast of rocky pharmaceutical markets could lead to uncertain financing condit...
CKD, Roche Korea forge partnership
Chong Kun Dang Pharmaceutical announced Tuesday that it has inked a business alliance agreement with Roche Korea.
Under the deal, CKD will be in charge of selling six Roche drugs using its extensive domestic distri...
Mvix S takes on Viagra, Cialis
SK Chemicals is enjoying brisk sales of its anti-impotence drug, Mvix S due to its new oral disintegrating film as a new dosage form.
The company said that the annual sales of Mvix S is expected to surge 30 billion...
LG Life Sciences targets 400 billion won in 2012 sales
LG Life Sciences aims to achieve 400 billion won in sales this year with the intention of emerging as one of research oriented companies, a company executive said Tuesday.
“We will reach 400 billion won in this yea...
New drug pricing policy squeezing drug firms
The government’s plan to cut drug prices by an average of 14 percent starting April has triggered vehement protests from the domestic pharmaceutical community.
A report released by the Korea Pharmaceutical Manufac...
Handok, Mitsubishi Tanabe announces licensing agreement for novel DPP-4 agent
Handok Pharma and Mitsubishi Tanabe Pharma announced Tuesday the execution of a license agreement granting Hanmi to market Mitsubishi Tanabe’s new dipeptidyl peptidase 4 (DPP-4 agent) MP-513 (teneligliptin) for the tr...
Hanmi, Spectrum enter agreement over neutropenia treatment
Hanmi Pharmaceutical said Tuesday that it has signed a co-development and commercialization Agreement with the US based Spectrum Pharmaceuticals on Hanmi’s new biopharmaceutical LAPS-GCSF (HM10460A/neutropenia drug)....
Huons gets KFDA approval for combination drug
Huons and CTC Bio said Tuesday that the Korea Food and Drug Administration has given the green light to Arigrel, which combines the two most commonly prescribed medicines, clopidogrel and aspirin, for the treatment of...
Celltrion’s international trademark applications top 23 in 2011
Biotech company Celltrion Inc. filed 23 Madrid system based trademark applications last year in an effort to protect its own medicines in the international arena, according to the Korean Intellectual Property Office (...
Can Rhu be renamed as KPMA chairman
Attention has been drawn on whether Rhu Duk-hee , chairman of the incumbent chairman of the Korea Pharmaceutical Manufacturers Association, could be re-appointed at the next month's general meeting.
Most of KPMA ex...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
